Life (Aug 2023)

COVID-19 and Laboratory Markers from Romanian Patients—A Narrative Review

  • Ovidiu Musat,
  • Virgiliu Bogdan Sorop,
  • Madalina Ioana Sorop,
  • Viorica Lazar,
  • Daniela Teodora Marti,
  • Monica Susan,
  • Cecilia Roberta Avram,
  • Andrada Oprisoni,
  • Dan Dumitru Vulcanescu,
  • Florin George Horhat,
  • Iulia Cristina Bagiu,
  • Delia Ioana Horhat,
  • Mircea Mihai Diaconu

DOI
https://doi.org/10.3390/life13091837
Journal volume & issue
Vol. 13, no. 9
p. 1837

Abstract

Read online

COVID-19 has significantly impacted the whole world, and Romania was no exception. Biomarkers play a crucial role in understanding and managing the disease. However, research regarding laboratory analyses for patients with COVID-19 is fairly limited. For detection, PCR testing is still considered the golden standard, while antibodies are still useful for monitoring both patients and their vaccination status. In our country, biomarkers such as CRP, LDH, transaminases, cardiac, and iron markers have been used to assess the status of patients and even predict illness outcome. CRP, IL-6, LDH, FER, fibrinogen, creatinine, and vitamin D levels have been associated with increased severity, risk of ICU admission, and death. Cardiac markers and D-dimers are also good predictors, but their role seems more important in patients with complications. HDL cholesterol and BUN levels were also suggested as potential biomarkers. Hematological issues in SARS-CoV-2 infections include neutrophilia, lymphopenia and their ratio, while PCT, which is a marker of bacterial infections, is better to be used in patients with co- or supra-infections. The current research is a narrative review that focuses on the laboratory results of Romanian COVID-19 patients. The goal of this article is to provide an update on the research on biomarkers and other laboratory tests conducted inside the borders of Romania and identify gaps in this regard. Secondly, options for further research are discussed and encouraged.

Keywords